Alternatively, the paradox whereby patients with higher BMI have better survival, despite excess weight being a risk factor for developing cancer, may be explained by an increased T-cell dysfunction and expression of PD-1 driven, in part, by leptin signaling, which may be reversed by checkpoint blockade [34]. Here, PDCD1 is linked to cancer.